z-logo
open-access-imgOpen Access
CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean
Author(s) -
Paula M. Luz,
Pablo F. Belaunzarán-Zamudio,
Brenda CrabtreeRamírez,
Yanink CaroVega,
Daniel Hoces,
Peter F. Rebeiro,
Meridith Blevins,
Jean W. Pape,
Claudia P. Cortés,
Denis Padgett,
Pedro Cahn,
Valdiléa G. Veloso,
Catherine C. McGowan,
Beatriz Grinsztejn,
Bryan E. Shepherd
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv079
Subject(s) - interquartile range , medicine , antiretroviral therapy , latin americans , human immunodeficiency virus (hiv) , caribbean region , virology , immunology , viral load , pediatrics , linguistics , philosophy
We describe CD4 counts at 6-month intervals for 5 years after combination antiretroviral therapy initiation among 12 879 antiretroviral-naive human immunodeficiency virus-infected adults from Latin America and the Caribbean. Median CD4 counts increased from 154 cells/mm3 at baseline (interquartile range [IQR], 60–251) to 413 cells/mm3 (IQR, 234–598) by year 5.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom